Market Place
Sourcing Support
NuCana`s Retooled Chemotherapy Fails To Increase Survival In Clinic
30 Aug 2024 //
FIERCE BIOTECH
NuCana`s twist on chemo drug Gemzar fails in phase 3 again
09 Mar 2022 //
FIERCEPHARMA
NuCana Announces Enrollment of Second Interim Analysis in Phase III BTC
22 Feb 2022 //
GLOBENEWSWIRE
NuCana Reports Second Quarter 2021 Financial Results
19 Aug 2021 //
GLOBENEWSWIRE
NuCana Presents Encouraging Data at ASCO GI for NUC-3373
15 Jan 2021 //
GLOBENEWSWIRE
NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin
05 May 2020 //
GLOBENEWSWIRE
NuCana Reports Preliminary Data from Phase II Study
10 Mar 2020 //
GLOBE NEWSWIRE
EMA issues positive opinion for NuCana`s acelarin in combo with cisplatin
06 Mar 2020 //
PHARMABIZ
NuCana Receives +ve Opinion for Orphan Drug Designation in the EUfor Acelarin
04 Mar 2020 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.